A Phase 1 interventional study of Weight loss in Obesity, sponsored by VA Office of Research and Development. Completed at 1 site in United States. Open to participants aged 25 Years to 60 Years. Per ClinicalTrials.gov, last updated 2026-05-12.
Sponsored by VA Office of Research and Development · Phase 1, Interventional, and Other
Obesity is a common problem in the Veteran population as at least 1 in 3 Veterans have obesity. When people with obesity taste food they have less response in areas of the brain that sense pleasure (reward). Decreased pleasure response to food predicts future weight gain. It is not known if this poor brain response is reversible or why obese people's brains respond this way. Insulin in the brain regulates the brain's sensing of pleasure. As people gain weight the function of insulin becomes impaired. The investigators will study if impaired function of insulin is related to a lessened brain response to food and if this brain response predicts voluntary intake of food and response to a low-calorie diet. The investigators will also study if improving the function of insulin with weight loss improves the brain response. These studies will improve the understanding as to why weight loss is difficult and inform us if improving insulin signaling is a potential way to treat obesity.
The current research proposal will investigate the relationship of insulin sensitivity to brain reward signaling. In most individuals with obesity, insulin signaling is impaired (insulin resistance). Preclinical animal studies suggest that insulin resistance in brain regions important for reward contribute to overeating. This proposal aims to test these hypotheses in humans and to determine if these characteristics are pertinent to clinical outcomes (food intake and weight loss). In humans increased body mass index (BMI) and weight gain occur with decreased food consumption-induced neural activation (consummatory reward) in the caudate of the dorsal striatum. It has been speculated that diminished consummatory reward causes overeating and prevents weight loss, however, this hypothesis has not been directly tested. Further, mechanisms for impaired food consumption-induced neural activation in obesity have not been investigated.
The research outcomes of the proposed study are: 1) taste-induced neural activation as determined by blood-oxygen dependent functional magnetic resonance imaging (BOLD fMRI) scanning, 2) caloric intake at a buffet meal, and 3) food craving. Based on screening and baseline outcome assessments participants with insulin resistance (metabolically unhealthy obesity) will be enrolled in a weight loss intervention to lose 5-10% body weight and then repeat outcomes measures after intervention. Those who are metabolically healthy at baseline (MHO) will only complete baseline outcome measures.
6,296 studies on the registry are indexed under Obesity; 1,692 are open to participants now.
This study's enrollment of 37 is below the median of 78 across 4,878 interventional studies indexed under Obesity.
Browse Obesity studies →VA Office of Research and Development is the lead sponsor of 1,733 studies on the registry; 396 are open to participants now.
Of its 206 completed or terminated interventional studies of FDA-regulated products, 180 (87%) have results posted.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Veterans with obesity and determined metabolically unhealthy, weight stable before attempting to lose 5-10% body weight with caloric restriction intervention Weight loss completers through dietary education for caloric restriction to lose 5-10% of body weight.
Behavioral: Weight loss
Veterans with obesity determined to be metabolically healthy and weight stable
Veterans with obesity who are metabolically unhealthy will undergo dietary intervention aiming for 5-10% weight loss
food consumption-induced neural activation
food consumption-induced neural activation as determined by blood-oxygen dependent functional magnetic resonance imaging (BOLD fMRI) scanning
Time frame: ~4-9months
Plan to share: No
This study is completed, as verified in May 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
VA Office of Research and Development